GW Pharmaceuticals plc (GWPH, GWP.L), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced the closing of its initial public offering of 3.50 million American Depository Shares or ADSs at a price to the public of $8.90 per share.
The company said it has granted the underwriters an option to purchase up to 525,000 additional ADSs at the initial public offering price to cover over-allotments, if any. GW's ADSs are listed on the NASDAQ Global Market under the trading symbol "GWPH" and began trading on May 1.
For comments and feedback: editorial@rttnews.com